Botulinum neurotoxin A decreases infiltrating cutaneous lymphocytes and improves acanthosis in the KC-Tie2 mouse model

Journal of Investigative Dermatology

Volumn 132, Issue 7, 2012, Pages 1927-1930

  Ward, Nicole L ^a,b   Kavlick, Kevin D ^a   Diaconu, Doina ^a   Dawes, Sean M ^a   Michaels, Kellie A ^a   Gilbert, Erin ^c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c Downstate Health Sciences University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; BOTULINUM TOXIN A; CALCITONIN GENE RELATED PEPTIDE; GLYCOPROTEIN P 15095; SUBSTANCE P; SYNAPTOSOMAL ASSOCIATED PROTEIN 25;

ACANTHOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DISEASE SEVERITY; HISTOPATHOLOGY; LETTER; LYMPHOCYTIC INFILTRATION; MOUSE; MOUSE STRAIN; NERVOUS SYSTEM; NEUROMUSCULAR SYNAPSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; STATISTICAL SIGNIFICANCE; STRESS; TREATMENT OUTCOME;

EID: 84862323012     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.60     Document Type: Letter

References (15)

1. Carmichael NM, Dostrovsky JO, Charlton MP (2010) Peptide-mediated transdermal delivery of botulinum neurotoxin type A reduces neurogenic inflammation in the skin. Pain 149:316-24
2. Chan J, Smoller BR, Raychauduri SP et al. (1997) Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis. Arch Dermatol Res 289:611-6 (Pubitemid 27510824)
3. Dewing SB (1971) Remission of psoriasis associated with cutaneous nerve section. Arch Dermatol 104:220-1
4. Farber EM, Lanigan SW, Boer J (1990) The role of cutaneous sensory nerves in the maintenance of psoriasis. Int J Dermatol 29:418-20 (Pubitemid 20252108)
5. Griffiths CE, Richards HL (2001) Psychological influences in psoriasis. Clin Exp Dermatol 26:338-42 (Pubitemid 34204348)
6. Jiang W-Y, Raychaudhuri SP, Farber EM (1998) Double-labeled immunofluorescence study of cutaneous nerves in psoriasis. Int J Dermatol 37:572-4 (Pubitemid 28389315)
7. Joachim RA, Kuhlmei A, Dinh QT et al. (2007) Neuronal plasticity of the "brain-skin connection": stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways. J Mol Med 85:1369-78 (Pubitemid 350234092)
8. Joseph T, Kurian J, Warwick DJ et al. (2005) Unilateral remission of psoriasis following traumatic nerve palsy. Br J Dermatol 152:185-6
9. Meng J, Wang J, Lawrence G et al. (2007) Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential. J Cell Sci 120:2864-74 (Pubitemid 47394260)
10. Naukkarinen A, Nickoloff BJ, Farber EM (1989) Quantification of cutaneous sensory nerves and their substance P content in psoriasis. J Invest Dermatol 92:126-9 (Pubitemid 19027707)
11. Ostrowski SM, Belkadi A, Loyd CM et al. (2011) Cutaneous denervation of psoriasiform mouse skin improves acanthosis and inflammation in a sensory neuropeptide-dependent manner. J Invest Dermatol 131:1530-8
12. Perlman HH (1972) Remission of psoriasis vulgaris from the use of nerve-blocking agents. Arch Dermatol 105:128-9
13. Remrod C, Lonne-Rahm S, Nordlind K (2007) Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus. Arch Dermatol Res 299:85-91 (Pubitemid 46669413)
14. Stratigos AJ, Katoulis AK, Stavrianeas NG (1998) Spontaneous clearing of psoriasis after stroke. J Am Acad Dermatol 38:768-70 (Pubitemid 28213726)
15. Zanchi M, Favot F, Bizzarini M et al. (2008) Botulinum toxin type-A for the treatment of inverse psoriasis. J Eur Acad Dermatol Venereol 22:431-6 (Pubitemid 351436912)